Monday, May 16, 2022 1:04:41 PM
There is little incentive to participate in discourse unless there is an agenda. Holders have understandable agendas. Those who do not hold have unknown agendas. And they are probably not altruistic in nature.
For what CUBT has---$23 Million in market cap is very low. Having the NIH fund the clinical trials alone is worthy of a higher valuation. A Patent in their IP portfolio is worth $$$.
A Priority Review Voucher (PRV) opportunity is worth more.
Multiple promising treatments with their biggest hurdle is capital to advance on all fronts.
But only $23 Million market cap?
There are other stocks out there that you could own and encourage others to join you. Why stay here?
Successful Trading is the art of minimizing long term risk and maximizing capital allocation.
Recent CUBT News
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 05/06/2024 09:31:41 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM